Journal article icon

Journal article

Association of guideline and policy changes with incidence of lifestyle advice and treatment for uncomplicated mild hypertension in Primary Care: a longitudinal cohort study in the Clinical Practice Research Datalink

Abstract:
Objectives Evidence to support initiation of pharmacological treatment in patients with uncomplicated (low risk) mild hypertension is inconclusive. As such, clinical guidelines are contradictory and healthcare policy has changed regularly. The aim of this study was to determine the incidence of lifestyle advice and drug therapy in this population and whether secular trends were associated with policy changes. Design Longitudinal cohort study. Setting Primary care practices contributing to the Clinical Practice Research Datalink in England. Participants Data were extracted from the linked electronic health records of patients aged 18–74 years, with stage 1 hypertension (blood pressure between 140/90 and 159/99 mm Hg), no cardiovascular disease (CVD) risk factors and no treatment, from 1998 to 2015. Patients exited if follow-up records became unavailable, they progressed to stage 2 hypertension, developed a CVD risk factor or received lifestyle advice/treatment. Primary outcome measures The association between policy changes and incidence of lifestyle advice or treatment, examined using an interrupted time-series analysis. Results A total of 108 843 patients were defined as having uncomplicated mild hypertension (mean age 51.9±12.9 years, 60.0% female). Patientsspent a median 2.6 years (IQR 0.9–5.5) in the study, after which 12.2% (95% CI 12.0% to 12.4%) were given lifestyle advice, 29.9% (95% CI 29.7% to 30.2%) were prescribed medication and 19.4% (95% CI 19.2% to 19.6%) were given both. The introduction of the quality outcomes framework (QOF) and subsequent changes to QOF indicators were followed by significant increases in the incidence of lifestyle advice. Treatment prescriptions decreased slightly over time, but were not associated with policy changes. Conclusions Despite secular trends that accord with UK guidance, many patients are still prescribed treatment for mild hypertension. Adequately powered studies are needed to determine if this is appropriate.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/ bmjopen-2018-021827

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
ORCID:
0000-0002-4461-8756
More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Primary Care Health Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences
Department:
Primary Care Health Sciences
Role:
Author


More from this funder
Funding agency for:
Sheppard, J
Hobbs, F
McManus, R
Grant:
MR/K022032/1
NIHR-RP-R2-12-015
More from this funder
Funding agency for:
Sheppard, J
Grant:
MR/K022032/1


Publisher:
BMJ Journals
Journal:
BMJ Open More from this journal
Volume:
8
Issue:
9
Publication date:
2018-09-05
Acceptance date:
2018-07-25
DOI:
EISSN:
2044-6055


Keywords:
Pubs id:
pubs:891819
UUID:
uuid:0f173b23-f4c0-43ee-945c-8cdafb969bc5
Local pid:
pubs:891819
Source identifiers:
891819
Deposit date:
2018-07-31

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP